Literature DB >> 12091071

Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy.

K F Kölmel1, B Kulle, A Lippold, C Seebacher.   

Abstract

The evaluation of the impact of prevention activities on the course of survival in conjunction with the individual hazard rate of dying is described using data from a follow-up study of 10433 melanoma patients during three observation periods (1972-1980, 1981-1988, 1989-1996). Kaplan-Meier survival curves combined with hazard functions were calculated. At all observation periods, survival of men was lower compared with women and their maximum dying risk was earlier (70 versus 100 months after removal of the primary tumour). In 1989-1996, differences in the survival rates were approximately halved compared with those for 1972-1980 or 1981-1988, respectively. This improvement was predominantly seen in young men. There was a lower survival rate of men compared with women with identical thickness categories. The maximum dying risk for those men with tumours >4 mm peaked at approximately 60 months, the other thickness categories showing a lower and later maximum; in women, the maximum dying risk for tumours >4 mm was also seen at approximately 60 months, but less pronounced. Over time, the influence of Breslow thickness on the survival rates remained constant in women; in men, with the exception of thick tumours, there was a trend towards a better survival. Melanoma awareness campaigns conducted in Germany since the late 1980s have resulted in a trend towards a remarkable increase of thin tumours in recent years, whereas the number of new cases with thick tumours has remained constant.

Entities:  

Mesh:

Year:  2002        PMID: 12091071     DOI: 10.1016/s0959-8049(02)00104-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 2.  Cancer progression and the invisible phase of metastatic colonization.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2020-10-06       Impact factor: 60.716

3.  Time course and pattern of metastasis of cutaneous melanoma differ between men and women.

Authors:  Liljana Mervic
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 4.  Is oestrogen an important player in melanoma progression?

Authors:  Marcelina E Janik; Klaudyna Bełkot; Małgorzata Przybyło
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

5.  Trends and projections in cutaneous melanoma death in the Netherlands from 1950 to 2045.

Authors:  Catharina C van Niekerk; Hans M M Groenewoud; André L M Verbeek
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.